# Olmesartan Pediatric Pharmacokinetic (PK) Study

> **NCT00151814** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 24 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Olmesartan medoxomil

## Key facts

- **NCT ID:** NCT00151814
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2010-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151814, "Olmesartan Pediatric Pharmacokinetic (PK) Study". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00151814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*